Photo from wikipedia
LENALIDOMIDE IN COMBINATION WITH R‐ESHAP IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: A PHASE 2 STUDY FROM THE SPANISH GROUP GELTAMO A. Martín* | M. Baile |… Click to show full abstract
LENALIDOMIDE IN COMBINATION WITH R‐ESHAP IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: A PHASE 2 STUDY FROM THE SPANISH GROUP GELTAMO A. Martín* | M. Baile | G. Rodríguez | I. Dlouhy | J.M. Sancho | I. Jarque | E. González‐Barca | A. Salar | M. Espeso | C. Grande | J. Bergua | S. Montes‐Moreno | A. López‐Guillermo | E. Campo | D. Caballero Hematology, Hospital Universitario de Salamanca and IBSAL, Salamanca, Spain; Hematology, UGC HH.UU. Virgen del Rocío / Virgen Macarena, Sevilla, Spain; Hematology, Hospital Clinic, Barcelona, Spain; Hematology, Hospital Germans Trias i Pujol / ICO‐IJC, Barcelona, Badalona, Spain; Hematology, Hospital Universitario La Fe, Valencia, Spain; Hematology, Hospital Duran i Reynals / ICO‐IDIBELL, Hospitalet de Llobregat, Barcelona, Spain; Hematology, Hospital del Mar, Barcelona, Spain; Hematology, Hospital Regional Universitario de Málaga, Málaga, Spain; Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain; Hematology, Hospital San Pedro de Alcántara, Cáceres, Spain; Pathology, Hospital Universitario Marqués de Valdecilla, Santander, Spain; Pathology, Hospital Clinic, Barcelona, Spain
Journal Title: Hematological Oncology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!